Clinical Trials in Baltimore

Showing 19501-19520 of 23,476 trials

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

NCT00029315

This is a study to evaluate how recombinant tissue plasminogen activator (rt-PA) is utilized in patients with intraventricular hemorrhage (IVH). rt-PA is a drug that has been shown to dissolve blood, and may allow intraventricular catheters to be more effective for a longer period of time.

Cerebral Hemorrhage

Johns Hopkins University30 participantsStarted Sep 2001

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

NCT00918606

An Evaluation of the PK and Safety of LIPO-102 in Healthy Volunteers.

Subcutaneous Adipose Tissue Reduction

Neothetics, Inc30 participantsStarted Feb 2009

Baltimore, Maryland, United States

COMPLETED7.7 miles

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

NCT00229658

This is an open label, observational study designed to collect data that characterize the use of SYMLIN following the introduction of the medication into the marketplace. Health care providers and subjects selected for study participation are intended to be representative of those providers prescribing, and subjects receiving, SYMLIN therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca1,297 participantsStarted Sep 2005

Birmingham, Alabama, United States • Montgomery, Alabama, United States • Tucson, Arizona, United States +104 more locations

Intraventricular Rt-PA in Patients With Intraventricular Hemorrhage

An Evaluation of the Pharmacokinetics and Safety of LIPO-102 in Healthy Volunteers

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Find Trials by Condition in Baltimore

Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil (SR-PAAS)

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

Phase IIIB Subcutaneous Abatacept Monotherapy Study

Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C

Dose Ranging Study

Safety and Efficacy Study of Glufosfamide in Previously Treated Advanced Soft Tissue Sarcoma

Effectiveness and Safety Study of the Iovera Device for the Temporary Reduction in the Appearance of Forehead Wrinkles

Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil) Vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxsentan Efficacy And Safety Trial With A Randomized Prospective Assessment Of Adding Sildenafil

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease

Study of Tauroursodeoxycholic Acid for Hepatobiliary Disease in Cystic Fibrosis

Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme